Literature DB >> 24122893

Studies on excretion kinetics of ten constituents in rat urine after oral administration of Shensong Yangxin Capsule by UPLC-MS/MS.

Minyan Liu1, Song Li, Shaohua Zhao, Hongtao Wang, Hairong Wang, Pengfei Tu.   

Abstract

A rapid and sensitive ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS/MS) method was developed and validated for the quantification of 10 major active constituents in rat urine after oral administration of Shensong Yangxin Capsule (SSYX) using diazepam as an internal standard (IS). The urine samples were pretreated and extracted by solid-phase extraction prior to UPLC. Chromatographic separation was achieved on a Waters C18 (2.1 × 50 mm, 1.7 µm) column using a gradient elution program with 0.1% formic acid aqueous solution and acetonitrile at a flow rate of 0.4 mL/min. Detection and quantitation were accomplished by a hybrid quadrupole mass spectrometer using electrospray ionization source and multiple reaction monitoring in the positive ionization mode. The mass transition ion-pairs (m/z) for quantitation were all optimized and the total run time was 4.50 min. The specificity, linearity, accuracy, precision, recovery, matrix effect and stabilities were all validated for the analytes in urine samples. The validation results indicated that this method was simple, rapid, specific and reliable. The proposed method was successfully applied to investigate the urinary excretion kinetics of 10 compounds in rat after oral administration of SSYX.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Shensong Yangxin Capsule; UPLC-MS/MS; multiple-reaction monitoring; solid-phase extraction; urinary excretion kinetics

Mesh:

Substances:

Year:  2013        PMID: 24122893     DOI: 10.1002/bmc.3064

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  2 in total

1.  Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial.

Authors:  Xi Wang; Dan Hu; Song Dang; He Huang; Cong-Xin Huang; Ming-Jie Yuan; Yan-Hong Tang; Qing-Shan Zheng; Fang Yin; Shu Zhang; Bo-Li Zhang; Run-Lin Gao
Journal:  Chin Med J (Engl)       Date:  2017-07-20       Impact factor: 2.628

2.  Shensong Yangxin Protects Against Metabolic Syndrome-Induced Ventricular Arrhythmias by Inhibiting Electrical Remodeling.

Authors:  Hong-Jie Yang; Bin Kong; Wei Shuai; Jing-Jing Zhang; He Huang
Journal:  Front Pharmacol       Date:  2020-07-09       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.